All the news Showing 10 of 40 articles from: EASL 2016Get an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Treatment in acute infection Six weeks of sofosbuvir/ledipasvir is enough to cure acute hepatitis C in HIV-negative people Liz Highleyman / 18 April 2016 A regimen of sofosbuvir/ledipasvir (Harvoni) taken for six weeks cured all patients with genotype 1 acute hepatitis C virus (HCV) infection, including those with high viral loads, according to findings from a ... Side effects Tenofovir alafenamide works well against hepatitis B with less effect on bones and kidneys Liz Highleyman / 18 April 2016 The new tenofovir alafenamide (TAF) pro-drug is as potent against hepatitis B virus (HBV) as the current tenofovir disoproxil fumarate (TDF) formulation, but with fewer detrimental effects on bone and kidney biomarkers, ... Access to medicines & diagnostics Low-cost generic hepatitis C drugs match branded products in viral responses Keith Alcorn / 16 April 2016 Generic versions of direct-acting antivirals purchased from China and India by people unable to obtain treatment in their own countries were just as effective and safe as the branded products, a study ... International policy Liver associations worldwide call for elimination of viral hepatitis Liz Highleyman / 15 April 2016 Leaders of liver disease associations from Europe, the US, Latin America and Asia released a Joint Society Statement on Elimination of Viral Hepatitis on Thursday at the opening session of the International ... Models of care Shifting hepatitis C treatment to primary care providers could expand availability Liz Highleyman / 15 April 2016 Hepatitis C treatment managed by non-specialists such as primary care physicians and nurse practitioners is as safe and effective as treatment delivered by specialists and could help increase the number of people receiving ... Hepatitis delta Study demonstrates benefits of existing treatment for hepatitis D patients EASL press release / 15 April 2016 Antiviral therapy Antiviral therapy prolongs survival in immune tolerant hepatitis B patients Eurekalert Inf Dis / 15 April 2016 Antiviral therapy Treatment for chronic hepatitis B linked to increased rates of colorectal and cervical cancer EASL press release / 15 April 2016 Liver transplants New HCV Therapies Might Ease Transplant Pressure MedPage Today Gastroenterology / 15 April 2016 Hepatocellular carcinoma (HCC) Nearly one-third of patients with previous HCC recur after DAA therapy Healio Hepatology / 15 April 2016 ← Prev1234Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive